Loxo Oncology

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Loxo Oncology and buy or sell other stocks, ETFs, and their options commission-free!

About LOXO

Loxo Oncology, Inc. is a biopharmaceutical company, which engages in the development of small molecule therapeutics for the treatment of cancer. It focuses on genetic alterations, targeted therapies, and genetic testing. 

CEO
Jacob S. van Naarden
CEOJacob S. van Naarden
Employees
Employees
Headquarters
Stamford, Connecticut
HeadquartersStamford, Connecticut
Founded
2013
Founded2013
Employees
Employees

LOXO Key Statistics

Market cap
7.17B
Market cap7.17B
Price-Earnings ratio
-112.57
Price-Earnings ratio-112.57
Dividend yield
Dividend yield
Average volume
479.60K
Average volume479.60K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$234.93
52 Week high$234.93
52 Week low
$103.50
52 Week low$103.50

Stock Snapshot

The current Loxo Oncology(LOXO) stock price is $234.73, with a market capitalization of 7.17B. The stock trades at a price-to-earnings (P/E) ratio of -112.57.

On 2026-03-02, Loxo Oncology(LOXO) shares started trading at —, with intraday highs of — and lows of —.

Trading activity shows a volume of 0, compared to an average daily volume of 479.6K.

Over the past 52 weeks, Loxo Oncology(LOXO) stock has traded between a high of $234.93 and a low of $103.50.

Over the past 52 weeks, Loxo Oncology(LOXO) stock has traded between a high of $234.93 and a low of $103.50.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.